Injecting When You're Sick
A stomach bug, flu, or COVID on top of a GLP-1 is a different situation than the same illness without one. Here's a practical guide to whether to take your shot — and how to avoid the most common avoidable complication.
The short answer
For a mild cold, sinus infection, or non-GI illness — generally yes, take your scheduled dose. For acute gastrointestinal illness with vomiting or diarrhea — generally hold the dose and check with your prescriber before the next one. The biggest avoidable risk in any GLP-1-related illness is dehydration leading to acute kidney injury (AKI). The drug stays in your system for days regardless of whether you inject this week, so skipping a single weekly dose during illness does not crash your therapy.
What to know
The drug has a long half-life, which changes the math. Semaglutide and tirzepatide both have half-lives of about 5-7 days. A single missed weekly dose during illness does not drop you to zero — it lowers your steady-state exposure modestly and gives your gut a small break while you recover. Skipping a dose for one week is far less consequential than dehydration from continuing it through a stomach bug.
GI illness on a GLP-1 hits harder. The drug already slows gastric emptying, suppresses appetite, and can cause nausea. Adding a viral gastroenteritis, food poisoning, or norovirus on top of that compounds the same symptoms. Patients often eat and drink less than they realize and may not feel thirsty even when meaningfully dehydrated. The result is a faster path from "uncomfortable" to "actually in trouble."
Acute kidney injury is the failure mode to know. Post-marketing reports and several published case series describe GLP-1-associated AKI, almost always in the setting of an intercurrent illness with reduced oral intake — vomiting, diarrhea, or just severely reduced eating. The mechanism is volume depletion in a kidney that may already be vulnerable. Older adults, people with chronic kidney disease, and people on diuretics or ACE inhibitors/ARBs are the highest-risk group.
Non-GI illnesses are usually fine to dose through. A respiratory virus, urinary tract infection, sinus infection, or skin infection without significant nausea, vomiting, or reduced intake is generally not a reason to skip a GLP-1 dose. Antibiotics for these conditions do not have meaningful interactions with semaglutide or tirzepatide.
COVID and flu deserve their own paragraph. Both can present with significant GI symptoms in addition to respiratory ones. If your COVID or flu episode is producing meaningful nausea, vomiting, or reduced intake, treat it like GI illness — hold the dose, prioritize hydration, and check with your prescriber. Paxlovid (nirmatrelvir/ritonavir) does not have major direct interactions with GLP-1s, but ritonavir is a CYP3A inhibitor and your prescriber should know about all your medications when starting it.
Practical steps
When you're sick
Hydrate first, dose later
If you can't keep fluids down for 12+ hours, that's the priority — not the next injection. Oral rehydration solution (Pedialyte, generic equivalents) is far more effective than water alone if you've been vomiting or having diarrhea.
Skip the dose for clear GI illness
Norovirus, stomach flu, food poisoning — if you're losing fluids from both ends or can't tolerate food, hold this week's injection and check with your prescriber before the next one.
Lower threshold to call after 65 or with CKD
If you're older or have any history of kidney issues, don't try to wait out a bad GI illness on a GLP-1. A urgent care visit for IV fluids is much smaller than an AKI hospitalization.
Common questions
Common Concerns
I'm sick on injection day. Should I take it?expand_more
How long can I skip before I lose progress?expand_more
What about Paxlovid for COVID?expand_more
Can I take anti-nausea medication?expand_more
What if I get the flu shot or COVID vaccine?expand_more
Keep exploring
Browse all GLP-1 guides.